Development of novel glyco-biomarkers for nonalcoholic steatohepatitis (NASH) based on the adipocytokine dysregulation
Project/Area Number |
24590972
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Osaka University |
Principal Investigator |
KAMADA YOSHIHIRO 大阪大学, 医学(系)研究科(研究院), 准教授 (30622609)
|
Co-Investigator(Kenkyū-buntansha) |
MIYOSHI Eiji 大阪大学, 医学系研究科, 教授 (20322183)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | 肝臓病 / 糖鎖 / バイオマーカー / 肝臓病学 / 非アルコール性脂肪性肝炎(NASH) / フコシル化ハプトグロビン / Mac-2 binding protein / アディポサイトカイン / Sfrp5 / (1) 非アルコール性脂肪性肝炎(NASH) / Mac2 binding protein |
Outline of Final Research Achievements |
Nonalcoholic steatohepatitis (NASH) is a growing medical problem, and can progress to liver cirrhosis and hepatocellular carcinoma. Now, liver biopsy remains the gold standard for the diagnosis and the grading liver disease severity in NASH patients. However, liver biopsy is an invasive test, and repeated liver biopsy for the estimation of NASH progression is hard to perform. Therefore, noninvasive NASH biomarkers are needed. We investigated pathophysiology of NASH focusing on adipocytokine and oligosaccharide. We found that lack of secreted frizzled related protein 5 accelerated the liver fibrosis progression. In addition, we established three glyco-biomarkers for NASH. Serum fucosylated haptoglobin and Mac-2 binding protein levels are useful for the NASH diagnosis, and suitable for the prediction of ballooning hepatocyte presence and liver fibrosis severity, respectively. We also found serum fetuin-A levels were decreased with the liver fibrosis progression of NASH patients.
|
Report
(4 results)
Research Products
(51 results)
-
[Journal Article] Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.2015
Author(s)
Kamada Y*, Sato M* (equally contributed), Takeda Y, Kida S, Ohara Y, Fujii H, Akita M, Mizutani K, Yoshida Y, Yamada M, Hougaku H, Takehara T, Miyoshi E.
-
Journal Title
Liver Int
Volume: 35
Issue: 3
Pages: 925-35
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
[Journal Article] Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.2015
Author(s)
Kamada Y*, Asazawa H* (equally contributed), Takeda Y, Takamatsu S, Shinzaki S, Kim Y, Nezu R, Kuzushita N, Mita E, Kat M, Miyoshi E.
-
Journal Title
Clin Chem Lab Med
Volume: 53
Issue: 1
Pages: 95-102
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
[Journal Article] N-Acetylglucosaminyltransferase V exacerbates concanavalin A‑induced hepatitis in mice.2015
Author(s)
Kamada Y, Sato M, Kida S, Akita M, Mizutani K, Fujii H, Sobajima T, Yoshida Y, Shinzaki S, Takamatsu S, Takehara T, Miyoshi E.
-
Journal Title
Mol Med Rep.
Volume: 5
Issue: 5
Pages: 3573-84
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis.2015
Author(s)
Chatani N, Kamada Y, Kizu T, Ogura S, Furuta K, Egawa M, Hamano M, Ezaki H, Kiso S, Shimono A, Ouchi N, Yoshida Y, Takehara T.
-
Journal Title
Liver Int
Volume: in press
Issue: 8
Pages: 2017-26
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
[Journal Article] Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice.2015
Author(s)
Kizu T, Yoshida Y, Furuta K, Ogura S, Egawa M, Chatani N, Hamano M, Takemura T, Ezaki H, Kamada Y, Nishida K, Nakaoka Y, Kiso S, Takehara T.
-
Journal Title
Am J Physiol Gastrointest Liver Physiol
Volume: 308
Issue: 7
Pages: 613-624
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Loss of α1,6-fucosyltransferase suppressed liver regeneration: implication of core fucose in the regulation of growth factor receptor-mediated cellular signaling.2015
Author(s)
Wang Y, Fukuda T, Isaji T, Lu J, Gu W, Lee HH, Ohkubo Y, Kamada Y, Taniguchi N, Miyoshi E, Gu J.
-
Journal Title
Sci Rep
Volume: in press
Issue: 1
Pages: 925-35
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.2015
Author(s)
Shimomura M, Nakayama K, Azuma K, Terao N, Nishino K, Takamatsu S, Nakano M, Takahashi S, Kobayashi Y, Murata K, Kamada Y, Miyoshi E.
-
Journal Title
Clin Chim Acta
Volume: in press
Pages: 30-6
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-
-
[Journal Article] Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.2013
Author(s)
Takemura T, Yoshida Y, Kiso S, Kizu T, Furuta K, Ezaki H, Hamano M, Egawa M, Chatani N, Kamada Y, Imai Y, Higashiyama S, Iwamoto R, Mekada E, Takehara T.
-
Journal Title
Biochem Biophys Res Commun.
Volume: 437
Issue: 2
Pages: 185-191
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet.2013
Author(s)
Kamada Y, Kiso S, Yoshida Y, Chatani N, Kizu T, Hamano M, Egawa M, Takemura T, Ezaki H, Furuta K, Hayashi N, Takehara T.
-
Journal Title
Hepatol Res.
Volume: 43
Issue: 4
Pages: 401-412
DOI
NAID
Related Report
Peer Reviewed
-
-
[Journal Article] Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.2013
Author(s)
Kamada Y, Kinoshita N, Tsuchiya Y, Kobayashi K, Fujii H, Terao N, Kamihagi K, Koyama N, Yamada S, Daigo Y, Nakamura Y, Taniguchi N, Miyoshi E.
-
Journal Title
Clin Chim Acta
Volume: 417
Pages: 48-53
DOI
Related Report
Peer Reviewed
-
[Journal Article] Serum fucosylated haptoglobin as a novel diagnostic biomarker for predicting hepatocyte ballooning and nonalcoholic steatohepatitis.2013
Author(s)
Kamada Y, Akita M, Takeda Y, Yamada S, Fujii H, Sawai Y, Doi Y, Asazawa H, Nakayama K, Mizutani K, Fujii H, Yakushijin T, Miyazaki M, Ezaki H, Hiramatsu N, Yoshida Y, Kiso S, Imai Y, Kawada N, Takehara T, Miyoshi E.
-
Journal Title
Related Report
Peer Reviewed
-
-
[Journal Article] Conditional knockout of heparin-binding epidermal growth factor-like growth factor in the liver accelerates carbon tetrachloride-induced liver injury in mice.2012
Author(s)
Takemura, T., YoshidaY., Kiso, S., Saji, Y., Ezaki, H., Hamano, M., Kizu, T., Egawa, M., Chatani, N., Furuta, K., Kamada, Y., Iwamoto, R., Mekada, E., Higashiyama, S., Hayashi, N. and Takehara, T.
-
Journal Title
Hepatol Res
Volume: 43
Issue: 4
Pages: 384-393
DOI
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Presentation] Fetuin-A negatively correlates with liver and vascular fibrosis in NAFLD subjects2014
Author(s)
Yoshihiro Kamada, Motoya Sato, Yuri Takeda, Sachiho Kida, Yuka Ohara, Hironobu Fujii, Maaya Akita, Kayo Mizutani, Yuichi Yoshida, Makoto Yamada, Hidetaka Hougaku, Tetsuo Takehara, Eiji Miyoshi
Organizer
AASLD The Liver Meeting 2014
Place of Presentation
Boston, U.S.A.
Year and Date
2014-11-09
Related Report
-
-
-
-
-
-
-
-
[Presentation] N-Acetylglucosaminyltransferase V (GnT-V) prevents mice steatohepatitis progression through modulation of lymphocytes and hepatic stellate cells function.2013
Author(s)
Yoshihiro Kamada, Kanako Mori, Hitoshi Matsumoto, Yuichi Yoshida, Shinichi Kiso, Shinichiro Shinzaki, Naoki Hiramatsu, Mayuko Ishii, Kenta Moriwaki, Norifumi Kawada, Tetsuo Takehara and Eiji Miyoshi
Organizer
国際類洞壁細胞研究会(ISCHS 2013)
Place of Presentation
大阪国際会議場(大阪)
Related Report
-
[Presentation] Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.2013
Author(s)
Yoshihiro Kamada, Hideki Fujii, Hironobu Fujii, Yoshinori Doi, Kayo Mizutani, Maaya Akita, Motoya Sato, Sachiho Kida, Noriaki Kinoshita, Nobuhiro Maruyama, Takayuki Yakushijin, Masanori Miyazaki, Hisao Ezaki, Naoki Hiramatsu, Yuichi Yoshida, Shinichi Kiso, Norifumi Kawada, Tetsuo Takehara and Eiji Miyoshi
Organizer
The 64th Annual Meeting of the American Association for the Study of Liver Diseases
Place of Presentation
Washington, USA
Related Report
-
-
-
-
-
-
-
-
-
-
-